Physician profile
Alisha Walker
NPI 1194977348
$5,167.50
in general payments reported to CMS, 2019-2025
46 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,075 · 2022: $1,352 · 2023: $1,605 · 2024: $15.69 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,740.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $824.02 | 2021-2023 | |
| Astrazeneca Pharmaceuticals Lp | $611.26 | 2021-2023 | Farxiga, Breztri, Tezspire |
| Lilly USA, LLC | $347.56 | 2021-2023 | Mounjaro, Jardiance, Emgality |
| Amgen INC. | $347.18 | 2021-2025 | Krystexxa, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $310.02 | 2021-2023 | Synjardy, Tradjenta, Glyxambi |
| Horizon Therapeutics Plc | $207.55 | 2023 | Krystexxa |
| Biohaven Pharmaceuticals, INC. | $177.45 | 2021 | |
| Merck Sharp & Dohme LLC | $163.17 | 2021-2023 | Gardasil 9, Vaxelis, M-M-R II |
| Otsuka America Pharmaceutical, INC. | $150.40 | 2021-2022 | |
| Astellas Pharma US INC | $141.04 | 2021-2023 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $140.17 | 2021-2023 | Eliquis |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $123.24 | 2023 | |
| Optinose US, INC. | $121.14 | 2021 | |
| Paratek Pharmaceuticals, INC. | $109.08 | 2021-2023 | Nuzyra |
| Novo Nordisk INC | $108.00 | 2021-2023 | Wegovy |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisha Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.